3D Rendered Illustration, cancer cell

Single-Cell Analysis of CTCs Improved via New Capture Technology

A team from the University of Michigan has recently developed Hydro-Seq, a new system to trap cancer cells one at a time in a...

Microfluidic Chip Captures More than 99% of CTCs

Scientists at the University of Georgia (UGA) College of Engineering have developed a new microfluidic device that separates circulating tumor cells (CTCs) from a...
QS6-Pro-Hi-Res-10IN

Improved User-qPCR Instrument Interaction

Thermo Fisher Scientific has launched what the company says are the first “smart” PCR instruments, its Applied Biosystems QuantStudio 6 and 7 Pro Real-Time...
Owlstone Medical will partner with Renji Hospital in Shanghai to conduct a clinical trial assessing the company's Breath Biopsy diagnostic breathalyzer platform in early detection of lung cancer

Owlstone Medical to Collaborate on Breath-Based Pulmonary Hypertension Test

Owlstone Medical, has announced a strategic collaboration with Switzerland-based Actelion Pharmaceuticals Ltd, leader in pulmonary arterial hypertension (PAH), to discover and validate a breath-based...

PerkinElmer, Helix Partner to Launch Genetic Screening Test

The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.

Former Foundation Medicine Execs Join Hopkins Kimmel Directors, VCs in New Company

Steven Kafka, Ph.D., the former president and chief operating officer of Foundation Medicine who left the company last year, has joined with former colleagues...
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.

U.S. Academies, U.K. Royal Society Launch Commission to Develop Germline Editing Framework

Nearly six months after He Jiankui, Ph.D., stunned the world by disclosing, then defending, his controversial germline editing research resulting in the birth of...
Scroll Up